\subsection{Table 8}
\textbf{\textit{Table8---Different Types of Termination Rights}} \\
\begin{tabular}{lcccccc}
 \hline \hline
& \multicolumn{4}{p{4cm}}{\begin{tabular}{p{4cm}}
Termination rights of financing firm (without requiring
broad property rights)\\ \hline \end{tabular}}
& \multicolumn{2}{p{4cm}}{\begin{tabular}{p{4cm}}
 Conditional termination and broad property rights \\ \hline
\end{tabular}}\\
&&&&OLS with year&&OLS with year\\
&Ordered&Ordered&& and firm fixed&&and firm fixed \\
&logit&logit&OLS&effects&OLS&effects\\
&(1)&(2)&(3)&(4)&(5)&(6) \\
\\ \hline
Date&-0.026& -0.023 &0.003 &&0.005\\
&[0.023] &[0.025] &[0.010] &&[0.003]\\
No specifiable lead product&-0.280&-0.273& -0.104 &-0.092 &0.024 &0.027\\
&[0.195]& [0.209]& [0.080]& [0.082]& [0.028]& [0.028]\\
Unknown if specifiable lead &-0.248 &-0.185 &-0.001 &-0.054 &-0.026 &-0.013\\
\quad product&[0.304] &[0.318] &[0.118] &[0.124] &[0.040] &[0.043]\\
\\
Agreement involves&-0.878&-0.887 &-0.287 &-0.274 &-0.043 &-0.052 \\
\quad diagnostic product&[0.290]***& [0.296]***& [0.103]***& [0.108]**& [0.035]& [0.037]\\
\\
Agreement involves&-0.480 &-0.406 &-0.156 -0.129 &0.029 &0.024 \\
\quad veterinary product&[0.411] &[0.418] &[0.152] &[0.158] &[0.052] &[0.055]\\
\\
Carter-Manaster rank of &0.003 &0.004& -0.013& -0.009 &0.006 &0.010\\
\quad lead underwriter of&[0.046] &[0.048] &[0.018] &[0.019] &[0.006]& [0.007] \\
\quad research firm`s IPO\\
\\
Number of patents of&&-0.003 &0.000 &-0.001 &-0.001 &-0.001\\
\quad research firm &[0.005] &[0.002]& [0.002] &[0.001] &[0.001]\\ 
\\
Financial Health Index&&0.873 &0.264 &0.235 &-0.103 &-0.080\\
&&[0.346]**& [0.131]**& [0.138]*& [0.045]**& [0.048]*\\
Number of previous research&&0.041 &0.002& -0.085& 0.034 &0.032\\ 
\quad agreements between&&[0.210]& [0.086] &[0.090] &[0.030] &[0.031]\\
\quad financing and research \\ 
\quad firms\\
\\
Constant&&&6.228 &1.088 &-8.996 &-0.026\\
&&&[19.888] &[0.850] &[6.829] &[0.294]\\
\\
Year fixed effects&&&&X&&X\\
\\
Financing company fixed&&&&X&&X\\
\quad effects (dummies for major \\
\quad pharmaceutical \\
\quad companies)
Observations&526 &483 &483 &483& 483 &483\\
$R^2$&&&0.03&0.12& 0.03 &0.10 \\ \hline

\end{tabular}
\input{Notes}